Viewing Study NCT05527795


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-01-04 @ 2:53 AM
Study NCT ID: NCT05527795
Status: RECRUITING
Last Update Posted: 2022-09-06
First Post: 2022-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module